Barclays’s Alaunos Therapeutics TCRT Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $0 | Sell |
100
-71
| -42% | – | ﹤0.01% | 4572 |
|
2025
Q1 | $0 | Buy |
+171
| New | – | ﹤0.01% | 4556 |
|
2022
Q4 | – | Sell |
-136,136
| Closed | -$234K | – | 4516 |
|
2022
Q3 | $234K | Buy |
+136,136
| New | +$234K | ﹤0.01% | 3001 |
|
2022
Q2 | – | Sell |
-35,027
| Closed | -$24K | – | 4912 |
|
2022
Q1 | $24K | Sell |
35,027
-219,407
| -86% | -$150K | ﹤0.01% | 4280 |
|
2021
Q4 | $278K | Buy |
254,434
+167,631
| +193% | +$183K | ﹤0.01% | 2738 |
|
2021
Q3 | $158K | Buy |
86,803
+56,748
| +189% | +$103K | ﹤0.01% | 3074 |
|
2021
Q2 | $80K | Sell |
30,055
-150,528
| -83% | -$401K | ﹤0.01% | 3218 |
|
2021
Q1 | $650K | Buy |
180,583
+109,061
| +152% | +$393K | ﹤0.01% | 2529 |
|
2020
Q4 | $180K | Sell |
71,522
-25,965
| -27% | -$65.3K | ﹤0.01% | 2741 |
|
2020
Q3 | $245K | Sell |
97,487
-22,295
| -19% | -$56K | ﹤0.01% | 2636 |
|
2020
Q2 | $393K | Buy |
119,782
+55,013
| +85% | +$180K | ﹤0.01% | 2467 |
|
2020
Q1 | $158K | Sell |
64,769
-125,576
| -66% | -$306K | ﹤0.01% | 2640 |
|
2019
Q4 | $898K | Buy |
190,345
+15,142
| +9% | +$71.4K | ﹤0.01% | 2362 |
|
2019
Q3 | $751K | Sell |
175,203
-111,517
| -39% | -$478K | ﹤0.01% | 2413 |
|
2019
Q2 | $1.67M | Buy |
286,720
+101,592
| +55% | +$592K | ﹤0.01% | 1956 |
|
2019
Q1 | $713K | Buy |
185,128
+103,566
| +127% | +$399K | ﹤0.01% | 2390 |
|
2018
Q4 | $152K | Sell |
81,562
-61,426
| -43% | -$114K | ﹤0.01% | 2825 |
|
2018
Q3 | $457K | Buy |
142,988
+107,918
| +308% | +$345K | ﹤0.01% | 2682 |
|
2018
Q2 | $106K | Buy |
35,070
+7,806
| +29% | +$23.6K | ﹤0.01% | 3039 |
|
2018
Q1 | $106K | Sell |
27,264
-53,668
| -66% | -$209K | ﹤0.01% | 3145 |
|
2017
Q4 | $335K | Buy |
80,932
+21,646
| +37% | +$89.6K | ﹤0.01% | 2349 |
|
2017
Q3 | $364K | Buy |
59,286
+58,620
| +8,802% | +$360K | ﹤0.01% | 2087 |
|
2017
Q2 | $5K | Sell |
666
-3,473
| -84% | -$26.1K | ﹤0.01% | 3549 |
|
2017
Q1 | $26K | Sell |
4,139
-48,699
| -92% | -$306K | ﹤0.01% | 3300 |
|
2016
Q4 | $283K | Buy |
52,838
+27,468
| +108% | +$147K | ﹤0.01% | 2116 |
|
2016
Q3 | $142K | Buy |
25,370
+25,270
| +25,270% | +$141K | ﹤0.01% | 2296 |
|
2016
Q2 | $1K | Sell |
100
-13,254
| -99% | -$133K | ﹤0.01% | 3468 |
|
2016
Q1 | $94K | Buy |
13,354
+13,199
| +8,515% | +$92.9K | ﹤0.01% | 2341 |
|
2015
Q4 | $1K | Sell |
155
-6,841
| -98% | -$44.1K | ﹤0.01% | 3121 |
|
2015
Q3 | $63K | Sell |
6,996
-2,608
| -27% | -$23.5K | ﹤0.01% | 2518 |
|
2015
Q2 | $115K | Buy |
9,604
+6,780
| +240% | +$81.2K | ﹤0.01% | 2305 |
|
2015
Q1 | $28K | Sell |
2,824
-288,998
| -99% | -$2.87M | ﹤0.01% | 2987 |
|
2014
Q4 | $1.46M | Buy |
291,822
+108,447
| +59% | +$543K | ﹤0.01% | 1448 |
|
2014
Q3 | $366K | Sell |
183,375
-168,291
| -48% | -$336K | ﹤0.01% | 2077 |
|
2014
Q2 | $1.41M | Sell |
351,666
-685,221
| -66% | -$2.74M | ﹤0.01% | 1541 |
|
2014
Q1 | $4.15M | Sell |
1,036,887
-360,307
| -26% | -$1.44M | ﹤0.01% | 1007 |
|
2013
Q4 | $5.59M | Buy |
1,397,194
+419,098
| +43% | +$1.68M | 0.01% | 957 |
|
2013
Q3 | $2.93M | Buy |
978,096
+387,129
| +66% | +$1.16M | ﹤0.01% | 1097 |
|
2013
Q2 | $1.25M | Buy |
+590,967
| New | +$1.25M | ﹤0.01% | 1596 |
|